M, Y., XC, T., CW, L., SL, L., CP, W., WL, M., . . . SH, K. (2026). Prospective phase II study of frontline Helicobacter pylori eradication therapy for early-stage extragastric mucosa-associated lymphoid tissue lymphoma. Blood cancer journal, 16(1), . https://doi.org/10.1038/s41408-026-01535-6
Chicago Style (17th ed.) CitationM, Yao, et al. "Prospective Phase II Study of Frontline Helicobacter Pylori Eradication Therapy for Early-stage Extragastric Mucosa-associated Lymphoid Tissue Lymphoma." Blood Cancer Journal 16, no. 1 (2026). https://doi.org/10.1038/s41408-026-01535-6.
MLA (9th ed.) CitationM, Yao, et al. "Prospective Phase II Study of Frontline Helicobacter Pylori Eradication Therapy for Early-stage Extragastric Mucosa-associated Lymphoid Tissue Lymphoma." Blood Cancer Journal, vol. 16, no. 1, 2026, https://doi.org/10.1038/s41408-026-01535-6.